Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 190

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

p53-Induced Adipose Tissue Inflammation Is Critically Involved in the Development of Insulin Resistance in Heart Failure

Open access
Shimizu, Ippei, Yoshida, Yohko, Katsuno, Taro, Tateno, Kaoru, Okada, Sho, Moriya, Junji, Yokoyama, Masataka, Nojima, Aika, Ito, Takashi, Zechner, Rudolf, Komuro, Issei, Kobayashi, Yoshio, Minamino, Tohru · 2012 · Cell Metabolism

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cmet.2011.12.006

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 42

  1. Arnlöv, 2001, Several factors associated with the insulin resistance syndrome are predictors of left ventricular systolic dysfunction in a male population after 20 years of follow-up, Am. Heart J., 142, 720, 10.1067/mhj.2001.116957 · DOI
  2. Asakawa, 2002, Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo, Circulation, 105, 1240, 10.1161/hc1002.105225 · DOI · Paper page
  3. Ashrafian, 2007, Metabolic mechanisms in heart failure, Circulation, 116, 434, 10.1161/CIRCULATIONAHA.107.702795 · DOI · Paper page
  4. Bazuine, 2009, Guardian of corpulence: a hypothesis on p53 signaling in the fat cell, Clin. Lipidol., 4, 231, 10.2217/clp.09.2 · DOI
  5. Benoit, 2006, Transcriptional activation of cyclooxygenase-2 by tumor suppressor p53 requires nuclear factor-kappaB, Oncogene, 25, 5708, 10.1038/sj.onc.1209579 · DOI
  6. Demas, 2001, Novel method for localized, functional sympathetic nervous system denervation of peripheral tissue using guanethidine, J. Neurosci. Methods, 112, 21, 10.1016/S0165-0270(01)00452-6 · DOI
  7. Edwards, 2007, Gene expression profiling of aging reveals activation of a p53-mediated transcriptional program, BMC Genomics, 8, 80, 10.1186/1471-2164-8-80 · DOI · Paper page
  8. Floras, 2009, Sympathetic nervous system activation in human heart failure: clinical implications of an updated model, J. Am. Coll. Cardiol., 54, 375, 10.1016/j.jacc.2009.03.061 · DOI · Paper page
  9. Foster, 2006, Sympathetic but not sensory denervation stimulates white adipocyte proliferation, Am. J. Physiol. Regul. Integr. Comp. Physiol., 291, R1630, 10.1152/ajpregu.00197.2006 · DOI
  10. Guo, 2009, Acipimox, an inhibitor of lipolysis, attenuates atherogenesis in LDLR-null mice treated with HIV protease inhibitor ritonavir, Arterioscler. Thromb. Vasc. Biol., 29, 2028, 10.1161/ATVBAHA.109.191304 · DOI
  11. Harada, 2005, G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes, Nat. Med., 11, 305, 10.1038/nm1199 · DOI · Paper page
  12. Home, 2009, Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial, Lancet, 373, 2125, 10.1016/S0140-6736(09)60953-3 · DOI · Paper page
  13. Hotamisligil, 1993, Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance, Science, 259, 87, 10.1126/science.7678183 · DOI · Paper page
  14. Iaccarino, 1999, Bbeta-adrenergic receptor kinase-1 levels in catecholamine-induced myocardial hypertrophy: regulation by beta- but not alpha1-adrenergic stimulation, Hypertension, 33, 396, 10.1161/01.HYP.33.1.396 · DOI
  15. Ingelsson, 2005, Insulin resistance and risk of congestive heart failure, JAMA, 294, 334, 10.1001/jama.294.3.334 · DOI · Paper page
  16. Kamei, 2006, Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance, J. Biol. Chem., 281, 26602, 10.1074/jbc.M601284200 · DOI · Paper page
  17. Kannel, 2000, Incidence and epidemiology of heart failure, Heart Fail. Rev., 5, 167, 10.1023/A:1009884820941 · DOI · Paper page
  18. Leizorovicz, 2002, Bisoprolol for the treatment of chronic heart failure: a meta-analysis on individual data of two placebo-controlled studies—CIBIS and CIBIS II. Cardiac Insufficiency Bisoprolol Study, Am. Heart J., 143, 301, 10.1067/mhj.2002.120768 · DOI
  19. Lopaschuk, 2007, Cardiac energy metabolism in obesity, Circ. Res., 101, 335, 10.1161/CIRCRESAHA.107.150417 · DOI · Paper page
  20. Marino, 2000, Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum, Genes Dev., 14, 994, 10.1101/gad.14.8.994 · DOI · Paper page
  21. Meek, 2009, Tumour suppression by p53: a role for the DNA damage response?, Nat. Rev. Cancer, 9, 714, 10.1038/nrc2716 · DOI · Paper page
  22. Minamino, 2008, Vascular aging: insights from studies on cellular senescence, stem cell aging, and progeroid syndromes, Nat. Clin. Pract. Cardiovasc. Med., 5, 637, 10.1038/ncpcardio1324 · DOI
  23. Minamino, 2009, A crucial role for adipose tissue p53 in the regulation of insulin resistance, Nat. Med., 15, 1082, 10.1038/nm.2014 · DOI · Paper page
  24. Nemoto, 2005, PPAR-gamma agonist rosiglitazone ameliorates ventricular dysfunction in experimental chronic mitral regurgitation, Am. J. Physiol. Heart Circ. Physiol., 288, H77, 10.1152/ajpheart.01246.2003 · DOI
  25. Neubauer, 2007, The failing heart—an engine out of fuel, N. Engl. J. Med., 356, 1140, 10.1056/NEJMra063052 · DOI · Paper page
  26. Nikolaidis, 2004, The development of myocardial insulin resistance in conscious dogs with advanced dilated cardiomyopathy, Cardiovasc. Res., 61, 297, 10.1016/j.cardiores.2003.11.027 · DOI
  27. Opie, 2004, The metabolic vicious cycle in heart failure, Lancet, 364, 1733, 10.1016/S0140-6736(04)17412-6 · DOI
  28. Packer, 2002, Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study, Circulation, 106, 2194, 10.1161/01.CIR.0000035653.72855.BF · DOI · Paper page
  29. Poole-Wilson, 2003, Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial, Lancet, 362, 7, 10.1016/S0140-6736(03)13800-7 · DOI · Paper page
  30. Royds, 2006, p53 and disease: when the guardian angel fails, Cell Death Differ., 13, 1017, 10.1038/sj.cdd.4401913 · DOI · Paper page
  31. Ryan, 2000, Role of NF-kappaB in p53-mediated programmed cell death, Nature, 404, 892, 10.1038/35009130 · DOI · Paper page
  32. Sano, 2007, p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload, Nature, 446, 444, 10.1038/nature05602 · DOI · Paper page
  33. Schnabel, 2000, Binding properties of beta-blockers at recombinant beta1-, beta2-, and beta3-adrenoceptors, J. Cardiovasc. Pharmacol., 36, 466, 10.1097/00005344-200010000-00008 · doi:10.1097/00005344-200010000-00008
  34. Sharma, 2007, Potential impact of carbohydrate and fat intake on pathological left ventricular hypertrophy, Cardiovasc. Res., 73, 257, 10.1016/j.cardiores.2006.11.007 · DOI
  35. Shimizu, 2010, Excessive cardiac insulin signaling exacerbates systolic dysfunction induced by pressure overload in rodents, J. Clin. Invest., 120, 1506, 10.1172/JCI40096 · DOI · Paper page
  36. Torp-Pedersen, 2007, Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET), Heart, 93, 968, 10.1136/hrt.2006.092379 · DOI · Paper page
  37. Tuunanen, 2006, Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure, Circulation, 114, 2130, 10.1161/CIRCULATIONAHA.106.645184 · DOI · Paper page
  38. Vousden, 2007, p53 in health and disease, Nat. Rev. Mol. Cell Biol., 8, 275, 10.1038/nrm2147 · DOI · Paper page
  39. Weisberg, 2003, Obesity is associated with macrophage accumulation in adipose tissue, J. Clin. Invest., 112, 1796, 10.1172/JCI200319246 · DOI · Paper page
  40. Witteles, 2008, Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options, J. Am. Coll. Cardiol., 51, 93, 10.1016/j.jacc.2007.10.021 · DOI · Paper page
  41. Young, 2002, Adaptation and maladaptation of the heart in diabetes: Part II: potential mechanisms, Circulation, 105, 1861, 10.1161/01.CIR.0000012467.61045.87 · DOI · Paper page
  42. Zeng, 2008, Saturated fatty acids modulate cell response to DNA damage: implication for their role in tumorigenesis, PLoS ONE, 3, e2329, 10.1371/journal.pone.0002329 · DOI

Cited by

See all 190

Metadata

Authors
Shimizu, I., Yoshida, Y., Katsuno, T., Tateno, K., Okada, S., Moriya, J., Yokoyama, M., Nojima, A., Ito, T., Zechner, R., Komuro, I., Kobayashi, Y., & Minamino, T.
Venue
Cell Metabolism
Publisher
Elsevier BV
Published
2012-01
Volume
15
Issue
1
Pages
51-64
ISSN
1550-4131 (ISSN-L)
OpenAlex
W1973712371
Cited by
190
References
16
FWCI
8.19
Type
journal article
Language
en
Open access
bronze
Licence
Funders
  • Naito Foundation
  • Ono Medical Research Foundation
  • Takeda Science Foundation
  • NOVARTIS Foundation (Japan) for the Promotion of Science
  • Uehara Memorial Foundation
  • Japan Diabetes Foundation
  • Ministry of Education, Culture, Sports, Science and Technology
  • Daiichi Sankyo Foundation of Life Science
  • Kowa Life Science Foundation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.